Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AstraZeneca Blames Germany’s Tender System For Influenza Vaccine Shortages

This article was originally published in The Pink Sheet Daily

Executive Summary

AstraZeneca says that shortages of influenza vaccines in Germany are a direct result of the tendering process there, which has blocked the firm’s Fluenz nasal spray product from being prescribed in several federal states.


Related Content

German Vaccine Reforms Offer Multiple Tenders; Firms Want Purchase Guarantees
Germany’s Vaccine Industry In Danger Of Disappearing, Says GSK
Germany’s New Non-Substitution Drug List No Big Bang For Pharma
EU Pricing Pressures On Generics And Biosimilars Risk Killing Industry –EGA Execs
German Pharma Industry Cries Foul As Preliminary Evaluation Of AMNOG Suggests It Works
AstraZeneca’s Brilique Triumphs As First Drug Through Germany’s New Pricing Process


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts